The DOA location deception effect of frequency diverse array on interferometer

With advances in radar localisation, especially the emergence and development of passive localisation, there is an urgent demand for countermeasure technology. To counteract the passive direction‐of‐arrival (DOA) location, this article studies the DOA location deception effect of a frequency diverse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:IET Radar, Sonar & Navigation Sonar & Navigation, 2021-03, Vol.15 (3), p.294-309
Hauptverfasser: Ge, Jiaang, Xie, Junwei, Wang, Bo, Chen, Chushu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:With advances in radar localisation, especially the emergence and development of passive localisation, there is an urgent demand for countermeasure technology. To counteract the passive direction‐of‐arrival (DOA) location, this article studies the DOA location deception effect of a frequency diverse array (FDA) on an interferometer. By analysing the phase distribution model of the uniform linear FDA (ULFDA) signal and the DOA location principle of the one‐dimensional phase interferometer, it was found that the phase difference the FDA produces does not conform to the direction‐finding law of the interferometer, which provides a potential capability for the FDA to achieve localisation deception for the interferometer. Based on the proposed DOA location deception model and the instantaneous signal‐to‐noise‐ratio (ISNR), the CRLB and RMSE of the angle and x‐intercept deviation are investigated. The results show that, compared with conventional phased array signals, the FDA signal can achieve DOA location deception on the interferometer, and by properly configuring the frequency increment sequence, the FDA can perform better DOA location deception on the interferometer, which means that the FDA provides promising potential for radar security.
ISSN:1751-8784
1751-8792
DOI:10.1049/rsn2.12032